FIGHTING FIBROSIS: NANOTECHNOLOGICAL AND GENETIC APPROACHES TO SILICOSIS TREATMENT
Keywords:
Silicosis, pulmonary fibrosis, HLA-DRB1*06 allele, nanomedicine, immunogenetics, antifibrotic therapy, traditional treatment methods, genetic predisposition, chronic lung diseases, nanoparticles, occupational diseases, pathogenesis, personalized medicine, anti-inflammatory therapy.Abstract
Silicosis is an occupational disease characterized by chronic and irreversible fibrosis of the lungs caused by inhalation of crystalline silica dust. Inflammation of the respiratory tract, oxidative stress, cell apoptosis, and tissue remodeling play important roles in the pathogenesis of the disease. Recent studies have shown that genetic factors, particularly the HLA-DRB1*06 allele, increase susceptibility to silicosis and aggravate its clinical course. Although traditional treatment methods cannot completely halt disease progression, new nanomedicine approaches can directly target lung tissue, effectively inhibiting inflammatory and fibrotic processes. This article analyzes nanomedical technologies and traditional therapeutic approaches in the treatment of silicosis, as well as personalized treatment strategies based on immunogenetic profiles. The mechanisms of targeted drug delivery using nanoparticles, their anti-inflammatory and antifibrotic effects, and the role of the HLA-DRB1*06 allele in disease pathogenesis and treatment response are discussed. The results of the study open new opportunities for effective management of fibrotic processes and treatment of silicosis, demonstrating that the integration of nanomedicine and genetic approaches is a promising way to control the disease at an individual level.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
- The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
- Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Notices:
You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation .
No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.
